News & Articles

The German-based biotech company specializes in process development for recombinant vaccines

Free white paper compares the pros and cons of various standard methods

The company is offering technical and scientific support along with supply chain continuity and instrument contributions

Following regulatory approval, the first clinical trial of the coronavirus vaccine candidates is said to commence in late April

UCL academics are working with Causaly to help accelerate research into the COVID-19 pandemic, including the identification of biomarkers and potential therapeutic agents

This strategic partnership aims to expand access to the Tapestri Platform for single-cell multiomics

The combination of the unique technologies aims to bring a novel angle to combat the global pandemic

Free white paper demonstrates the benefits of applied near-infrared spectroscopy

The device enables researchers to analyze their cell cultures remotely, hence minimizing time spent in high-containment labs

The AIHTA have published a comprehensive overview of current research and development activities for evidence-based policy advice

Torx enables collaborative team work and information delivery to accelerate the DMTA workflow for small-molecule discovery

Single-cell analysis for therapeutic discovery recognized with prestigious business award for innovation

The project has been launched by Viravaxx and the Medical University of Vienna

Proposed study intended to evaluate the safety and efficacy of opaganib in up to 60 patients hospitalized with positive SARS-CoV-2 infection and pneumonia in the U.S.

Biosero offers free Green Button Go Automation Scheduling Software to research teams to accelerate the treatment and prevention of COVID-19

The team at the University of Edinburgh believe new therapies could be discovered before a vaccine becomes available